Cargando…
Optimising the Management of Malignant Melanoma during COVID-19
Autores principales: | Hurley, C.M., Wrafter, L., Dhannoon, A., Regan, H., Regan, P.J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8574124/ https://www.ncbi.nlm.nih.gov/pubmed/34778506 http://dx.doi.org/10.1016/j.jpra.2021.09.004 |
Ejemplares similares
-
A Midwestern Academic HIV Clinic Operation during the COVID-19 Pandemic: Implementation Strategy and Preliminary Outcomes
por: Fadul, Nada, et al.
Publicado: (2021) -
Childhood immunization during the COVID-19 pandemic in Texas
por: Nuzhath, Tasmiah, et al.
Publicado: (2021) -
Guidance for design and analysis of observational studies of fetal and newborn outcomes following COVID-19 vaccination during pregnancy
por: Fell, Deshayne B., et al.
Publicado: (2021) -
The human herpesvirus-type 8 is not involved in malignant melanoma
por: Deichmann, M, et al.
Publicado: (1999) -
Characterising non-melanoma skin cancer undergoing surgical management during the COVID-19 pandemic
por: Capitelli-McMahon, Helen, et al.
Publicado: (2021)